Stay updated with breaking news from With Medicare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GatewaySeq, a genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis, has been approved for reimbursement by the Centers for Medicare & Medicaid Services.
More than 7 million Americans are receiving a Part B penalty, costing an average of $5,000 over their Medicare lifetime, all because they did not enroll at the right time.
With Medicare annual open enrollment about to close on Dec. 7, Medicare experts are discovering many insurance plans are dropping some insulin coverage in…
The NAR REALTOR Benefits® Team discusses the benefits of REALTORS® Insurance Place.